Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers.

In a double-blind, placebo-controlled study, self-administered intranasal human interferon alpha A produced by recombinant DNA technology was given both before and after virus challenge with a respiratory coronavirus. The incidence of colds, the severity of symptoms and signs, and virus replication...

Full description

Saved in:
Bibliographic Details
Main Authors: Higgins, P G, Phillpotts, R J, Scott, G M, Wallace, J, Bernhardt, L L, Tyrrell, D A
Format: Artigo
Language:Inglês
Published: 1983
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC185930/
https://ncbi.nlm.nih.gov/pubmed/6318655
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items